Form 4 for TECH Bio-Techne
Accepted 2025-07-24 00:00:00 ET · period of report 2025-07-22 · accession 0001062993-25-013134 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-24 | 2025-07-22 | TECH | Kelderman Kim | CEO, Dir | F - Tax | $53.12 | -43.6K | 46.7K | -48% | -$2.32M |
| D | 2025-07-24 | 2025-07-22 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $44.33 | +48.2K | 90.4K | +114% | +$2.14M |
| D | 2025-07-24 | 2025-07-22 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $0.00 | -48.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-22 | F | D | 43,649 | $53.12 | 46,730 | D | — | — | |
| 2 | Common | Common Stock | 2025-07-22 | M | A | 48,176 | $44.33 | 90,379 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-07-22 | M | D | 48,176 | $0.00 | 0 | D | $44.33 · — to 2025-08-08 | 48,176 Common Stock | (F1) Fully exercisable. |